Popular

• 

  RestartResume

  The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC

  MinuteCE®

  The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC

  • 

    

    Harry Yoon, MD

    Peer

  0.75 program credits

• 

  RestartResume

  Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA

  MinuteCE®

  Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA

  • 

    

    James R. Bateman, MD, MPH

    Peer

  • 

    

    B. Joy Snider, MD, PhD

    Peer

  • 

    

    Jerome A. Barakos, MD

    Peer

  1.25 program credits

• 

  MinuteCE®

  Differentiating First-Line Treatment Selection: Combination Immunotherapy and Chemotherapy Regimens for Metastatic ESCC

  • 

    

    Harry Yoon, MD

    Peer

  • 

    

    Jaffer Ajani, MD

    Peer

  0.75 credits 7 episodes

• 

  RestartResume

  Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers

  CME/CE

  Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers

  • 

    

    Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC

    Peer

  • 

    

    Rishi Wadhera, MD, MPP, Mphil

    Peer

  1.00 credits

• 

  RestartResume

  Clinical Conundrums in ARIA: How to Manage Asymptomatic ARIA

  MinuteCE®

  Clinical Conundrums in ARIA: How to Manage Asymptomatic ARIA

  • 

    

    James R. Bateman, MD, MPH

    Peer

  • 

    

    B. Joy Snider, MD, PhD

    Peer

  • 

    

    Jerome A. Barakos, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Three months of DAPT after PCI

  ACC Action Center

  Three months of DAPT after PCI

  • 

    

    Anna Bortnick, MD, PhD

    Peer

• 

  RestartResume

  Diagnosing and Treating Benign Prostatic Hyperplasia and Overactive Bladder

  Clinician's Roundtable

  Diagnosing and Treating Benign Prostatic Hyperplasia and Overactive Bladder

  • 

    

    Bilal Chughtai, MD

    Peer

• 

  RestartResume

  Evaluating the Safety of Ixekizumab in Psoriasis and Arthritis Patients

  Clinician's Roundtable

  Evaluating the Safety of Ixekizumab in Psoriasis and Arthritis Patients

  • 

    

    Atul A. Deodhar, MD, MRCP

    Peer

• 

  RestartResume

  Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data

  NeuroFrontiers

  Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data

  • 

    

    Jennie Taylor, MD

    Peer

• 

  RestartResume

  Improving the Detection and Prevention of PPD: The Potential Role of Biomarkers

  Advances in Women's Health

  Improving the Detection and Prevention of PPD: The Potential Role of Biomarkers

  • 

    

    Ashley Baker, MSN, PMHNP

    Peer

  • 

    

    Lauren Osborne, MD

    Peer

• 

  RestartResume

  HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)

  Project Oncology®

  HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)

  • 

    

    Fernando López-Ríos, MD, PhD

    Peer

  • 

    

    Christian Rolfo, MD, PhD

    Peer

  • 

    

    Charlie Gourley, MD, PhD

    Peer

• 

  RestartResume

  mIDH Gliomas Explained: Characteristics and Management Strategies

  NeuroFrontiers

  mIDH Gliomas Explained: Characteristics and Management Strategies

  • 

    

    Jennie Taylor, MD

    Peer

• 

  RestartResume

  From Diagnosis to Treatment: Challenges in Glioblastoma Care

  NeuroFrontiers

  From Diagnosis to Treatment: Challenges in Glioblastoma Care

  • 

    

    Lauren Schaff, MD

    Peer

• 

  RestartResume

  Dapagliflozin reduces worsening HF in elderly TAVI patients

  ACC Action Center

  Dapagliflozin reduces worsening HF in elderly TAVI patients

  • 

    

    Wayne Batchelor, MD

    Peer

• 

  RestartResume

  Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations

  NeuroFrontiers

  Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations

  • 

    

    Andrew J. Solomon, MD

    Peer